Correspondence 0001193125-24-008576 from IN8BIO, INC. (INAB) (CIK 0001740279) (INAB)
IN8BIO, INC. (INAB) (CIK 0001740279)
Date: Jan. 16, 2024 · CIK: 0001740279 · Accession: 0001193125-24-008576
AI Filing Summary & Sentiment
File numbers found in text: 333-276504
Show Raw Text
CORRESP 1 filename1.htm CORRESP IN8BIO, INC. 350 5th Avenue, Suite 5330 New York, New York 10118 January 16, 2024 VIA EDGAR Securities and Exchange Commission Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Daniel Crawford Re: IN8bio, Inc. (CIK No. 0001740279) Registration Statement on Form S-3 File No. 333-276504 Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, IN8bio, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) to become effective as of 4:00 p.m. Eastern time, on January 18, 2024, or as soon thereafter as possible, or at such other time as its legal counsel, Cooley LLP, may request by telephone to the Staff. Once the Registration Statement has been declared effective, please confirm that event with Sarah Curry of Cooley LLP by phone at (212) 479-6652 or by e-mail at sarah.curry@cooley.com. [Signature page follows] Very truly yours, IN8bio, Inc. /s/ William Ho By: William Ho Title: President and Chief Executive Officer [Signature Page to Acceleration Request]